Related Experiment Video
Updated: Feb 11, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Replication study: androgen receptor splice variants determine taxane sensitivity in prostate cancer
Xiaochuan Shan1, Gwenn Danet-Desnoyers1, Fraser Aird2
1Stem Cell and Xenograft Core, Perelman School of Medicine, Philadelphia, PA, USA.
Abstract:
In 2015, as part of the Prostate Cancer Foundation-Movember Foundation Reproducibility Initiative, we published a Registered Report (Shan et al., 2015) that described how we intended to replicate selected experiments from the paper "Androgen Receptor Splice Variants Determine Taxane Sensitivity in Prostate Cancer" (Thadani-Mulero et al., 2014). Here we report the results of those experiments. Growth of tumor xenografts from two prostate cancer xenograft lines, LuCaP 86.2, which expresses wild-type androgen receptor (AR) and AR variant 567, and LuCaP 23.1, which expresses wild-type AR and AR variant 7, were not affected by docetaxel treatment. The LuCaP 23.1 tumor xenografts grew slower than in the original study. This result is different from the original study, which reported significant reduction of tumor growth in the LuCaP 86.2. Furthermore, we were unable to detect ARv7 in the LuCaP 23.1, although we used the antibody as stated in the original study and ensured that it was detecting ARv7 via a known positive control (22rv1, Hörnberg et al., 2011). Finally, we report a meta-analysis of the result.
Insights
Replication experiments showed docetaxel did not affect prostate cancer xenograft growth. Researchers could not detect androgen receptor variant 7 (ARv7) in LuCaP 23.1, differing from the original study.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Prostate cancer treatment sensitivity is linked to androgen receptor (AR) splice variants.
- Previous studies suggested AR variants influence response to taxane chemotherapy.
Purpose of the Study:
- To replicate experiments investigating the role of AR splice variants in taxane sensitivity in prostate cancer.
- To validate findings from Thadani-Mulero et al., 2014.
Main Methods:
- Tumor xenografts (LuCaP 86.2 and LuCaP 23.1) were treated with docetaxel.
- AR expression and variant presence were assessed.
- A meta-analysis of results was performed.
Main Results:
- Docetaxel treatment did not significantly affect the growth of LuCaP 86.2 or LuCaP 23.1 xenografts.
- LuCaP 23.1 xenografts exhibited slower growth than reported in the original study.
- Androgen receptor variant 7 (ARv7) was not detected in LuCaP 23.1 xenografts, despite using the original antibody and a positive control.
Conclusions:
- The replication study did not confirm the taxane sensitivity conferred by AR splice variants as reported previously.
- Discrepancies in xenograft growth and ARv7 detection highlight potential reproducibility challenges in this research area.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
Internal Receptors
DNA Replication
Replication in Prokaryotes
DNA replication...
Histone Variants at the Centromere
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...

